Flecainide Acetate (Ranbaxy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Flecainide Acetate drug offered from Ranbaxy Pharmaceuticals Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Flecainide |
SUBSTANCE NAME: | FLECAINIDE ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiarrhythmic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-02-28 |
END MARKETING DATE: | 0000-00-00 |
Flecainide Acetate HUMAN PRESCRIPTION DRUG Details:
Item Description | Flecainide Acetate from Ranbaxy Pharmaceuticals Inc. |
LABELER NAME: | Ranbaxy Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2004-02-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63304-794_f13a72ef-8d6e-42e8-985e-d31ec9c07525 |
PRODUCT NDC: | 63304-794 |
APPLICATION NUMBER: | ANDA076421 |
Other FLECAINIDE ACETATE Pharmaceutical Manufacturers / Labelers: